Vaccine against CMV shows promise in clinical trial

A new vaccine has the potential to be the first to prevent maternal and congenital cytomegalovirus (CMV) infection, according to a University of Alabama at Birmingham (UAB) study published in the March 19 edition of the New England Journal of Medicine.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news156615651.html">Vaccine against CMV shows promise in clinical trial</a></p> <p>A new vaccine has the potential to be the first to prevent maternal and congenital cytomegalovirus (CMV) infection, according to a University of Alabama at Birmingham (UAB) study published in the March 19 edition of the <i>New England Journal of Medicine</i>. </p>